GINWA(SH:600080)2016-04-21 16:00Financial Performance - Net profit attributable to shareholders was CNY 3,041,021.22, representing a year-on-year increase of 27.41%[6] - Operating revenue decreased by 28.61% year-on-year to CNY 141,198,303.74[6] - The net cash flow from operating activities was CNY 7,722,008.22, a significant recovery from a negative cash flow of CNY -1,367,272.61 in the same period last year[6] - Earnings per share rose by 28.21% to CNY 0.0100[6] - Operating income was CNY 323,318.41, down CNY 1,371,087.19 or 80.92% from the previous year, due to the end of government compensation related to factory relocation[14] - Net profit for Q1 2016 reached ¥2,899,884.53, an increase of 23.9% from ¥2,341,521.68 in Q1 2015[27] - The net profit attributable to shareholders of the parent company was ¥3,041,021.22, compared to ¥2,386,763.43 in the previous year, reflecting a growth of 27.5%[27] - The company reported an operating profit of ¥3,596,030.88, up 62% from ¥2,220,125.84 in the same quarter last year[27] - Net profit for Q1 2016 reached ¥5,340,859.78, up 120.5% from ¥2,423,779.41 in Q1 2015[29] - Operating profit increased to ¥6,005,301.18, compared to ¥2,296,521.88 in the previous year, marking a growth of 161.5%[29] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,258,246,972.10, a slight increase of 0.01% compared to the previous year[6] - Total current assets at the end of the period were CNY 476,698,778.36, slightly up from CNY 472,650,715.46 at the beginning of the year[18] - Total liabilities amounted to CNY 209,381,534.49, down from CNY 212,126,175.58 at the beginning of the year[20] - The company's equity attributable to shareholders was CNY 1,048,196,220.82, up from CNY 1,045,155,199.60 at the beginning of the year[20] - Total assets as of the end of Q1 2016 amounted to ¥1,193,238,431.46, slightly up from ¥1,185,275,161.99 at the end of the previous year[24] - Total liabilities for Q1 2016 were ¥143,319,737.58, an increase of 1.5% from ¥140,697,327.89 in the previous year[24] Cash Flow - Cash and cash equivalents increased to CNY 24,014,341.59 from CNY 21,749,354.45 at the beginning of the year[18] - The company reported a total cash inflow from operating activities of ¥153,313,693.87, compared to ¥209,129,639.85 in the previous year, indicating a decrease of 26.8%[31] - Total cash outflow from operating activities was ¥145,591,685.65, down from ¥210,496,912.46 in the same period last year[31] - The company experienced a net cash outflow from investing activities of ¥15,577,927.72, compared to a net outflow of ¥2,920,903.89 in Q1 2015[32] Shareholder Information - The number of shareholders at the end of the reporting period was 35,585[9] - The largest shareholder, Jinhua Investment Holding Group Co., Ltd., held 48,000,000 shares, accounting for 15.72% of total shares[9] Operating Costs and Expenses - Operating costs for the reporting period were CNY 53,896,903.88, a decrease of CNY 78,387,107.56 or 59.26% compared to the previous year, primarily due to a significant reduction in low-margin agency business from the pharmaceutical subsidiary[14] - Sales expenses amounted to CNY 67,779,408.96, an increase of CNY 19,828,635.82 or 41.35% year-on-year, mainly driven by revenue growth in the pharmaceutical industry during the first quarter[14] - Financial expenses were reported at CNY -323,029.83, an increase of CNY 1,814,752.09 or 84.89%, attributed to a decrease in recognized investment income during the reporting period[14] - Operating expenses totaled CNY 430,405.98, a decrease of CNY 709,866.31 or 62.25% year-on-year, also linked to the conclusion of government compensation for factory relocation[14] - Total operating costs for Q1 2016 were ¥137,273,751.62, down 29.8% from ¥195,573,367.13 in Q1 2015[26] - Selling expenses for Q1 2016 were ¥67,779,408.96, a significant increase of 41.5% compared to ¥47,950,773.14 in Q1 2015[27]